Trial intelligence / Profile preview

Dexmedetomidine for prophylactic analgesia and sedation after craniotomy with delayed extubation

ChiCTR-PRC-12002903Phase 4Completed

Sponsor
Capital Medical University
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by Capital Medical University. Primary endpoint: Mean percentage of time in optimal sedation. Started Jul 2012; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR-PRC-12002903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-PRC-12002903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call